UNH Ticker Curator

$700B re-rating from Medicare Advantage rate shock signals end of managed care excess era, hitting profitability for players like UNH.

Post-earnings dip: UNH shares fell 3.3% since Q4 2025 report, underperforming S&P 500, hit by MCR at 91.5% (up 640 bps YoY) and rising medical...

UNH's diversified model drives edge over Humana post-Q4 2025.

• Revenues: UNH +12.3% YoY (UnitedHealthcare +17.5%, Optum +8%) vs. Humana +11.3%
  -...

• AIMZ Investment Advisors grew its UNH position 89.8% in Q3 to 15,316 shares ($5.29M), ~1.7% of portfolio and 15th-largest holding.
• Move amid 23%...

Aristotle Growth Equity Fund fully exited its UNH stake in Q4 2025, as revealed in their investor letter. Key signal for institutional sentiment—check the full letter for details.

Investor timeline on UNH's mixed Q4 2025 results:

• EPS hits forecast of $2.11
• Company fell short on results
• Shares close up 3.74% at $284.20, high volume
• Premarket +0.29% to $285.02; gains lift Dow

Key takeaways from trader's portfolio review on UNH:

• Monitoring a critical price zone in UnitedHealth Group
• Analyzing support/resistance levels...

Dividend Declaration

• 🔥 Quarterly Payout: UnitedHealth Group has declared a quarterly dividend of $2.21 per share, reflecting a forward yield of...

UNH shares at $273.95, down 5.2% weekly and 23.1% monthly, reflect sharp pressure from cyberattack fallout and cautious 2026 outlook. Heightened investment risks ahead.

UnitedHealth (UNH) signals strong shareholder commitment with a $2.21 quarterly dividend per share, delivering a 3.14% forward yield – key for income-focused investors.

UNH insider transaction highlights:

• CAO Thomas Roos granted 9,768 non-qualified options, 2,436 common shares, with 151.777 shares withheld for...

Investors, mark April 16, 2026 for UNH's next earnings release—building on a recent 0.96% positive surprise.